Core Scientific, Inc. Common Stock (CORZ)vsSynopsys Inc (SNPS)
CORZ
Core Scientific, Inc. Common Stock
$15.81
-4.07%
TECHNOLOGY · Cap: $5.18B
SNPS
Synopsys Inc
$420.32
-1.85%
TECHNOLOGY · Cap: $82.24B
Smart Verdict
WallStSmart Research — data-driven comparison
Synopsys Inc generates 2410% more annual revenue ($8.01B vs $319.02M). SNPS leads profitability with a 13.8% profit margin vs -90.5%. SNPS earns a higher WallStSmart Score of 51/100 (C-).
CORZ
Avoid29
out of 100
Grade: F
SNPS
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CORZ.
Margin of Safety
-858.5%
Fair Value
$44.68
Current Price
$420.32
$375.64 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 61.2% YoY
Conservative balance sheet, low leverage
Revenue surging 65.5% year-over-year
Large-cap with strong market position
Reasonable price relative to book value
Areas to Watch
ROE of 0.0% — below average capital efficiency
Revenue declined 16.0%
Negative free cash flow — burning cash
Distress zone — elevated risk
ROE of 5.5% — below average capital efficiency
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : CORZ
The strongest argument for CORZ centers on EPS Growth, Debt/Equity.
Bull Case : SNPS
The strongest argument for SNPS centers on Revenue Growth, Market Cap, Price/Book. Revenue growth of 65.5% demonstrates continued momentum.
Bear Case : CORZ
The primary concerns for CORZ are Return on Equity, Revenue Growth, Free Cash Flow.
Bear Case : SNPS
The primary concerns for SNPS are Return on Equity, Piotroski F-Score, PEG Ratio. A P/E of 65.3x leaves little room for execution misses.
Key Dynamics to Monitor
CORZ profiles as a turnaround stock while SNPS is a growth play — different risk/reward profiles.
CORZ carries more volatility with a beta of 6.90 — expect wider price swings.
SNPS is growing revenue faster at 65.5% — sustainability is the question.
SNPS generates stronger free cash flow (822M), providing more financial flexibility.
Bottom Line
SNPS scores higher overall (51/100 vs 29/100) and 65.5% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Core Scientific, Inc. Common Stock
TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA
Core Scientific, Inc. provides blockchain and artificial intelligence (AI) infrastructure services in the United States. The company is headquartered in Austin, Texas.
Visit Website →Synopsys Inc
TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA
Synopsys is an American electronic design automation company that focuses on silicon design and verification, silicon intellectual property and software security and quality. Products include logic synthesis, behavioral synthesis, place and route, static timing analysis, formal verification, hardware description language (SystemC, SystemVerilog/Verilog, VHDL) simulators, and transistor-level circuit simulation.
Visit Website →Compare with Other SOFTWARE - INFRASTRUCTURE Stocks
Want to dig deeper into these stocks?